MedPath

Does a single oral dose of dexamethasone after successful emergency department treatment of migraine reduce the incidence or severity of rebound headache within 48 hours?

Phase 4
Completed
Conditions
Migraine
Neurological - Other neurological disorders
Registration Number
ACTRN12605000034639
Lead Sponsor
The Joseph Epstein Centre for Emergency Medicine Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
76
Inclusion Criteria

Consenting adult patients with physician-diagnosed migraine treated in the ED who are willing and able to be contacted between 48-72 hours after discharge for follow-up.

Exclusion Criteria

Failure to consent. Pregnancy. Allergy to study medication. Findings inconsistent with migraine. Patients requiring hospital admission for further investigation and treatment. Patients with active peptic ulcer disease. Patients with Type 1 diabetes. Patients taking corticosteroids for another condition within 7 days. Active systemic fungal infection. Patients previously enrolled in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of patients who were discharged pain free that have a recurrence of headache within 48 hours[48 hours];Proportion of patients who were not pain free at discharge whose headache is worse or unchanged within 48 hours[48 hours]
Secondary Outcome Measures
NameTimeMethod
Comparison of headache severity.[At Hospital Discharge];Analgesia/ health service use[48 hours];Adverse events and return to normal functioning between the groups.[48 hours]
© Copyright 2025. All Rights Reserved by MedPath